Blogs, insights, guides and videos on India's unlisted market — all in one place.
<strong>1. Introduction</strong> Ncl-Buildtek, an unlisted company, recently published its financial results for the fiscal year 2023 (FY23), showcasing a remarkable performance across various key indicators. The company witnessed significant growth in revenue, a surge in profit after tax (PAT), and notable improvements in gross margins and EBITDA margins. These positive outcomes highlight Ncl-Buildtek's successful strategies in navigating market challenges and positioning itself for future growth. <strong>2. Robust Revenue Growth: </strong> In FY23, Ncl-Buildtek's revenue reached 450 Cr, reflecting a substantial increase of 13% compared to the previous fiscal year. This growth indicates the company's ability to expand its market presence and capitalize on emerging opportunities within its industry. <strong>3. Improved Gross Margins:</strong> One of the standout achievements for Ncl-Buildtek was the improvement in gross margins. With raw material prices decreasing, the company's gross margins rose from 39% in FY22 to an impressive 43% in FY23. This positive development signifies a successful mitigation of inflationary pressures on raw materials, leading to increased profitability and better cost management. <strong>4. Enhanced EBITDA Margins:</strong> Ncl-Buildtek showcased notable improvements in its EBITDA margins, rising from 7.3% in FY22 to 10.19% in FY23. This demonstrates the company's efforts in optimizing its operational efficiency, controlling costs, and maximizing profitability. The enhanced EBITDA margins position Ncl-Buildtek favorably within its sector and highlight effective management practices. <strong>5. Surge in Profit After Tax (PAT)</strong> The company's profit after tax witnessed a remarkable jump, soaring from 11 Cr in FY22 to 20 Cr in FY23, reflecting a staggering increase of nearly 100%. This exceptional growth underscores Ncl-Buildtek's ability to generate higher returns and deliver value to its stakeholders. <strong>6. Favorable Valuation</strong> With an earnings per share (EPS) of 16 in FY23 and an unlisted market price of 260, Ncl-Buildtek is available at a price-to-earnings (P/E) ratio of 16x. This valuation metric suggests a reasonable investment opportunity for potential investors interested in the company. <strong>7. Conclusion</strong> Ncl-Buildtek's financial performance for FY23 has been outstanding, with robust revenue growth, improved gross margins, enhanced EBITDA margins, and a surge in profit after tax. The company's ability to navigate market challenges and capitalize on favorable conditions highlights its strong management practices and strategic decision-making. The positive financial results position Ncl-Buildtek as an attractive investment opportunity for individuals seeking exposure to a promising company in the unlisted market. However, it's important to note that before making any investment decisions, individuals should conduct thorough research, assess their risk tolerance, and seek advice from financial professionals. The UnlistedZone website provides further information for investors interested in exploring investment opportunities in Ncl-Buildtek. https://unlistedzone.com/shares/buy-sell-share-price-ncl-alltek-seccolor-limited-unlisted-shares/
<strong>BoAt Sails Towards Higher Growth: Steers Focus on Software</strong> Innovation and Offline Expansion Robust Sale Growth and Expansion Plan India's leading wearables brand, BoAt, has announced record net sales of approximately Rs 4000 crore ($500 million) in FY2023, marking a 20-22% growth over the previous fiscal year. Leveraging its stronghold in audio products and recent boom in smartwatches, the company now targets an ambitious addition of Rs 1,000 crore to its revenue this fiscal Year. <strong>Manufacturing And Local Procurement</strong> Co-founder Sameer Mehta said, "The company assembled around 15 million products in India, including 70% of its audio products and around 98% of its smartwatches." This reflects a steadfast commitment towards promoting indigenous manufacturing. The company plans to source most of the components for audio products locally from India, including mechanics, plastic molds, speaker drivers, and batteries. BoAt has partnered with a host of contract manufacturers, including Dixon Technologies, to accelerate its manufacturing prowess. The joint venture is expected to be operational later this year. Despite the increasing local production, the company still relies on Chinese design houses for conducting design and engineering verification tests. <strong>Innovation through Strategic Partnership</strong> As part of its strategy to enhance the value of its products, BoAt is seeking partnerships with industry giants such as Qualcomm, Dolby, and Dirac. This will particularly benefit the company's audio product line, which accounts for 70% of its revenue and saw a phenomenal 82% year-on-year growth in Q1 2023. <strong>Transition from Hardware-First to Software Ecosystem</strong> Sameer Mehta hinted at a strategic shift for the company's smartwatches, moving from a hardware-centric model to a more comprehensive software-based ecosystem. This transition aims to make the watches more than just step counters and heart rate monitors, by introducing features related to health and wellness as part of a broader IoT play. To bolster its software capabilities, BoAt acquired the Singapore-based KaHa platform in May 2022. Since then, it has launched a range of innovative features, such as a reward platform for meeting health goals, which has also been updated in some of its older wearable. <strong>Growth Amid Competition</strong> Despite the ongoing expansion and market penetration of rivals like Fire-Boltt, BoAt plans to carefully craft its strategy before venturing into overseas markets. Mehta emphasised the need to establish the brand beyond simply shipping products to new markets. <strong>Conclusion</strong> BoAt's unwavering commitment to the 'Make in India' initiative, coupled with aggressive investment in software and application development, positions it well for continued success. With a distinctive strategy and dedication to product quality, BoAt is set to sail smoothly in the competitive waters of India's wearable mark https://unlistedzone.com/shares/boat-unlisted-share-price/
Kannur International Airport, a key player in Kerala's aviation sector, is currently embroiled in a severe financial crisis. With the Kannur Airport Unlisted Share facing unprecedented uncertainty, the management is contemplating significant strategic shifts to mitigate the situation. In the face of these financial challenges, the management is actively exploring the possibility of transferring its operations to the Tata Group. Privatization efforts have been initiated, with the Tata Group being a potential buyer. This move might bring about operational efficiency and improved financial stability, offering a potential respite to the Kannur Airport Unlisted Share. In a similar vein, the recent takeover of Thiruvananthapuram Airport by the Adani Group has stirred interest in Kannur Airport. This development indicates a growing trend towards privatization in the Indian aviation sector, and suggests potential competition in the privatization process. The financial strain at Kannur International Airport Limited (KIAL) is clearly evidenced by a two-month delay in salary payments to its employees. Such indicators of financial distress add to the uncertainty surrounding the Kannur Airport Unlisted Share. The operation of international flights from Kannur is currently limited. This constraint potentially reduces the airport's income from landing fees, passenger service charges, and other revenue sources. Moreover, domestic airlines operating from Kannur Airport have raised their fares, resulting in a decrease in passenger numbers and further impacting revenues. Presently, Kannur Airport's services are limited to two providers: Air India Express and IndiGo. This situation, too, limits the airport's sources of airline-related income, adding to the financial challenges. The financial liabilities associated with Kannur Airport are significant. An initial loan of INR 2,350 crores taken for the airport's construction has snowballed to INR 1,100 crores due to accumulated interest. With the loan's repayment period having expired, the airport now faces considerable debt servicing issues. In conclusion, the Kannur Airport Unlisted Share faces significant uncertainty amid the ongoing financial crisis. The potential transfer of the airport's management to the Tata Group, alongside the broader trend towards privatization in the Indian aviation sector, may bring about substantial changes in the airport's operational and financial landscape.
<p><strong>Introduction:</strong> <br /><br />PharmEasy, a prominent online pharmacy platform, has recently announced its partnership with Avendus Capital to raise equity funding. This move comes as PharmEasy aims to secure additional funds to meet a crucial covenant in the loan it received from Goldman Sachs. The company's existing investors, including Prosus Ventures, Temasek Holdings, CDPQ, and TPG, have expressed interest in investing up to INR 250 Cr in PharmEasy. Avendus Capital is also expected to explore opportunities to attract external investors for this fundraising endeavor. Let's delve deeper into the details and implications of this development. <br /><br /><strong>PharmEasy's Equity Funding Plans:<br /><br /></strong> In its current funding round, PharmEasy is aiming to raise up to $100 Mn (INR 824.64 Cr), which will supplement the INR 550 Cr it raised through a rights issue in 2022. The primary objective of this funding is to fulfill a key covenant in the loan agreement with Goldman Sachs. To achieve this, PharmEasy intends to raise INR 250 Cr to meet the loan covenant and allocate the remaining funds towards fulfilling its working capital requirements. <br /><br /><strong>Avendus Capital's Role:</strong> <br /><br />Avendus Capital, a trusted financial services firm, has been appointed as the advisor for PharmEasy's equity funding drive. Notably, Avendus Capital also served as the advisor during PharmEasy's successful Series C funding round in September 2018, which raised $50 Mn. Avendus Capital's involvement in both fundraising efforts underscores the confidence and strategic value they bring to PharmEasy's growth trajectory. <br /><br /><strong>Operational Profitability and Loan Obligations:</strong> <br /><br />PharmEasy's operational EBITDA profitability, excluding ESOP costs, has been instrumental in negotiating a smaller equity raise compared to the initial INR 1,000 Cr sought by the lender. The company's ability to demonstrate profitability has enabled it to secure a funding goal of INR 250 Cr to meet the loan covenant. The remaining funds will be utilized to support the company's working capital needs, ensuring its continued expansion and service excellence. <br /><br /><strong>PharmEasy's Acquisition and Subsidiary:</strong> <br /><br />PharmEasy borrowed INR 2,280 Cr ($285 Mn) from Goldman Sachs in August 2022 to settle a previous debt incurred from Kotak Mahindra Bank related to the acquisition of Thyrocare, a subsidiary of PharmEasy. Despite interest from potential acquirers, PharmEasy's founders are resisting the sale of Thyrocare, recognizing its strategic significance within the company. In June 2021, PharmEasy's parent company, API Holdings, acquired a 66% stake in Thyrocare for INR 4,546 Cr, which necessitated the debt raised from Kotak Mahindra Bank and subsequently Goldman Sachs. <br /><br /><strong>Financial Performance and Valuation:</strong> <br /><br />For the fiscal year ending on March 31, 2022, PharmEasy witnessed a substantial increase in revenue from operations, reaching INR 5,729 Cr compared to INR 2,235 Cr in the previous fiscal year. However, the company's losses also grew from INR 641 Cr in FY21 to INR 2,731 Cr in FY22. Recently, investors Neuberger Berman and Janus Hendersen marked down PharmEasy's valuation to $2.8 Bn, highlighting the need for continued financial investments to drive profitability and investor confidence. <br /><br /><strong>Conclusion:</strong> <br /><br />PharmEasy's collaboration with Avendus Capital to raise equity funding reflects the company's commitment to secure the necessary resources to meet its loan obligations and support its growth initiatives. With the backing of existing investors and potential external investors, PharmEasy aims to raise up to INR 250 Cr in this funding.</p>
<span style="font-weight: 400;">Axles India Limited has announced its annual financial results for the fiscal year 2022-2023. Following are the key highlights from the report. </span> <span style="font-weight: 400;">Axles India Limited achieved a remarkable milestone in terms of total revenue, reporting Rs. 745.93 crore in FY23. This represented a substantial growth rate of 30.73% compared to the previous fiscal year's revenue of Rs. 572.37 crore.</span> <span style="font-weight: 400;">The company's total expenses for FY23 were Rs. 675.20 crore, reflecting an increase of 28.19% compared to Rs. 527.19 crore in FY22.</span> <span style="font-weight: 400;">Axles India Limited demonstrated a robust performance in terms of profitability, as its profit before tax in FY23 amounted to Rs. 70 crore. This marked a significant increase of 55% compared to the previous fiscal year's figure of Rs. 45 crore.</span> <span style="font-weight: 400;">The company's profit after tax for FY23 reached Rs. 52 crore, signifying a growth rate of 66% from the previous fiscal year's profit of Rs. 33 crore.</span> <span style="font-weight: 400;">Axles India Limited's earnings per share (basic and diluted) in FY23 stood at Rs. 20.66, showcasing a substantial rise of 55.91% from the EPS of Rs. 13.28 in FY22.</span> <span style="font-weight: 400;">In FY23, Axles India Limited's total assets amounted to Rs. 416.45 crore, a notable increase of 12.23% compared to Rs. 371.09 crore in FY22.</span> <span style="font-weight: 400;">The company's total equity and liabilities in FY23 stood at Rs. 416.45 crore, indicating a growth rate of 12.23% from the previous fiscal year's figure of Rs. 371.09 crore</span> <span style="font-weight: 400;">Cash generated from operating activities in FY23 amounted to Rs. 17.78 crore, reflecting a significant increase of approximately 32.4% compared to the previous fiscal year.</span> <span style="font-weight: 400;">The company invested Rs. 12.21 crore in various activities during FY23, marking an increase of approximately 33.2% compared to FY22.</span> <span style="font-weight: 400;">Cash utilized in financial activities during FY23 amounted to Rs. 16.58 crore, indicating a decrease of approximately 16.5% compared to FY22.</span> <span style="font-weight: 400;">At the end of FY23, the company held Rs. 5.71 crore in cash and cash equivalents, representing a substantial decrease of approximately 65.9% compared to FY22. </span>
<strong>Key highlights from Mahindra Fastener Limited's annual financial report for the financial year ended March 31, 2023, are as follows:</strong> <span style="font-weight: 400;">Total revenue increased by 25% to Rs. 139 crore compared to the previous financial year.</span> <span style="font-weight: 400;">Total expenses rose by 27% to Rs. 155 crore compared to the previous financial year.</span> <span style="font-weight: 400;">Profit before tax grew by 25% to Rs. 20 crore compared to the previous financial year.</span> <span style="font-weight: 400;">Net profit after tax increased by 25% to Rs. 15 crore compared to the previous financial year.</span> <span style="font-weight: 400;">Earnings per share (EPS) (basic and diluted) were Rs. 25.55, compared to Rs. 23 in the previous financial year.</span> <span style="font-weight: 400;">Total assets increased to Rs. 168 crore compared to Rs. 141 crore in the previous financial year.</span> <span style="font-weight: 400;">Total equity and liabilities also increased to Rs. 168 crore compared to Rs. 141 crore in the previous financial year.</span> <span style="font-weight: 400;">Net cash generated from operating activities increased to Rs. 6 crore compared to Rs. 3 crore in the previous financial year.</span> <span style="font-weight: 400;">Total cash used in investing activities decreased to Rs. 19 crore compared to Rs. 21 crore in the previous financial year.</span> <span style="font-weight: 400;">Net cash generated from financial activities decreased to Rs. 4 crore compared to Rs. 15 crore in the previous financial year.</span> <span style="font-weight: 400;">Net cash and cash equivalents at the end of the year amounted to Rs. 11 crore compared to Rs. 19 crore in the previous financial year.</span> <span style="font-weight: 400;">These highlights provide an overview of Mahindra Fastener Limited's financial performance, showing growth in revenue, expenses, profit, and assets. The company also generated more cash from operating activities while reducing cash used in investing activities. However, there was a decrease in cash generated from financial activities, and the net cash and cash equivalents decreased by the end of the year. </span>
Mohan Meakin, a prominent company in the Indian market, has released its financial results for fiscal year 2022 (FY22) and fiscal year 2023 (FY23). This article aims to provide an overview of the company's financial performance during these periods, highlighting key metrics such as revenue, EBITDA, profitability, cash generation, and valuation. Additionally, a comparison table will be presented to facilitate a better understanding of Mohan Meakin's progress and changes over the two years. <strong>Financial Performance Comparison: FY22 vs. FY23</strong> <table width="100%"> <thead> <tr> <th style="text-align: center;">Metric</th> <th style="text-align: center;">FY22</th> <th style="text-align: center;">FY23</th> </tr> </thead> <tbody> <tr> <td>Revenue (in INR crore)</td> <td>1380</td> <td>1780</td> </tr> <tr> <td>EBITDA (in INR crore)</td> <td>76</td> <td>96</td> </tr> <tr> <td>EBITDA Margins</td> <td>5.55%</td> <td>5.39%</td> </tr> <tr> <td>Profit After Tax (PAT)</td> <td>51</td> <td>68</td> </tr> <tr> <td>Earnings Per Share (EPS)</td> <td>60</td> <td>80</td> </tr> <tr> <td>Free Cash Generated</td> <td>37</td> <td>16</td> </tr> <tr> <td>Return on Equity (ROE)</td> <td>34%</td> <td>25%</td> </tr> <tr> <td>Return on Capital Employed (ROCE)</td> <td>30.8%</td> <td>30%</td> </tr> <tr> <td>Price-to-Earnings (P/E)</td> <td>-</td> <td>17.5x</td> </tr> <tr> <td>Market Capitalization (Mcap)</td> <td>-</td> <td>1200 crore</td> </tr> </tbody> </table> <strong>Revenue FY23:</strong> The company recorded a revenue of INR 1780 crore, indicating a significant increase from the previous fiscal year. FY22: The revenue for FY22 stood at INR 1380 crore. <strong>EBITDA FY23:</strong> Mohan Meakin's EBITDA for FY23 reached INR 96 crore, reflecting a positive growth trajectory. FY22: The company reported an EBITDA of INR 76 crore in FY22. <strong>EBITDA Margins FY23:</strong> The EBITDA margins for FY23 were 5.39%, suggesting a slight decrease compared to the previous year. FY22: Mohan Meakin's EBITDA margins for FY22 were slightly higher at 5.55%. <strong>Profit After Tax (PAT) FY23:</strong> The company achieved a PAT of INR 68 crore in FY23, indicating improved profitability. FY22: Mohan Meakin reported a PAT of INR 51 crore in FY22. <strong>Earnings Per Share (EPS) FY23:</strong> The EPS for FY23 amounted to INR 80, showcasing a positive growth trend. FY22: In FY22, the EPS was INR 60. <strong>Debt and Free Cash Generation FY23:</strong> Mohan Meakin remains a debt-free company. The free cash generated during FY23 amounted to INR 16 crore, reflecting a decrease compared to the previous fiscal year. FY22: The company generated free cash of INR 37 crore in FY22. <strong>Return on Equity (ROE) FY23:</strong> The ROE for FY23 was 25%, suggesting a decline compared to the previous year. FY22: Mohan Meakin achieved an ROE of 34% in FY22. <strong>Return on Capital Employed (ROCE) FY23:</strong> The ROCE for FY23 remained relatively stable at 30%. FY22: In FY22, Mohan Meakin's ROCE was 30.8%. <strong>Valuation:</strong> The market valuation of Mohan Meakin stood at a price-to-earnings (P/E) ratio of 17.5x, indicating investor confidence in the company's performance. The market capitalization (Mcap) was recorded at INR 1200 crore. <strong>Conclusion:</strong> Mohan Meakin's financial performance in FY23 demonstrates substantial growth in terms of revenue, EBITDA, PAT, and EPS. Although there were slight declines in EBITDA margins, ROE, and free cash generation, the company remained debt-free and maintained a consistent ROCE. The favorable valuation metrics, including the P/E ratio and market capitalization, indicate a positive market sentiment towards Mohan Meakin's future prospects. As the company continues to navigate the business landscape, it will be interesting to observe its strategic initiatives and their impact on future financial results. https://unlistedzone.com/shares/mohan-meakin-limited-share-price-buy-sell-mohan-meakin-unlisted-shares/
<p><strong>1.</strong> API Holdings, the parent company of PharmEasy, has requested the Union Health Minister, Mansukha Mandaviya, to expedite the notification of draft e-pharmacy rules. <br /><br /><strong>2.</strong> The request comes after the Drug Controller General of India (DCGI) issued show-cause notices to about 20 online pharmacies for alleged violation of norms in February. <br /><br /><strong>3.</strong> API Holdings, in a letter to the Health Minister, asked for an urgent meeting to discuss issues and sought support for quick notification of the draft e-pharmacy rules and the New Drugs, Medical Devices and Cosmetics Bill 2022. <br /><br /><strong>4.</strong> The company hopes to eliminate regulatory uncertainty and harmonize all existing regulations under which e-pharmacies are already compliant<strong>.<br /><br />5</strong>. Although the government has proposed draft legislation multiple times, a formal framework for e-pharmacies has yet to be established. <br /><br /><strong>6.</strong> The Health Ministry had released a draft notification in 2018 that regulated e-pharmacies, but these rules were never finalized. <br /><br /><strong>7.</strong> In March of this year, a parliamentary committee on commerce urged the Ministry of Health and Family Welfare to finalize the e-pharmacy rules, stating that delays in defining a regulatory framework were causing uncertainty and hindering the growth of digital markets. <br /><br /><strong>8.</strong> Retail chemist organizations have protested against the sale of online medicines through e-pharmacies due to the lack of regulation. <br /><br /><strong>9.</strong> API Holdings defended the e-pharmacy sector, stating it provides quality and affordable medicines to about 100 million families across India and employment to about 150,000 skilled professionals. They expressed concern about the negative narrative questioning the legitimacy of the e-pharmacy model, which they believe is causing chaos among professionals employed by e-pharmacies. <br /><br /><a href="https://unlistedzone.com/shares/pharmeasy-share-price-unlisted-2022/">https://unlistedzone.com/shares/pharmeasy-share-price-unlisted-2022/</a></p>
<p><strong>1.</strong> According to reports, Tiger Global, a well-known investor with a technology focus, is in negotiations to buy a financial share in the Rajasthan Royals, an Indian Premier League (IPL) franchise. <br /><br /><strong>2.</strong> The Rajasthan Royals will receive an investment of about Rs.32 Cr from the New York-based company, who values the franchise at Rs.5200 Cr. whereas <a href="https://unlistedzone.com/shares/csk-share-price-buy-sell-unlisted-shares/">Chennai Super Kings</a> is currently valued at ~5700 Crores in the unlisted market. <br /><br /><strong>3.</strong> With this investment, Tiger Global is diversifying beyond its current emphasis on the internet commerce industry, where it is recognised for supporting firms like Flipkart, and entering India's athletic economy. <br /><br /><strong>4.</strong> The transaction may involve a direct or indirect money infusion, with Tiger Global maybe supporting one of the Rajasthan Royals' current shareholders. <br /><br /><strong>5.</strong> Manoj Badale, a UK-based investor who owns more than 60% of the shares of the franchise, is the owner of Rajasthan Royals' parent company, Emerging Media. <br /><br /><strong>6.</strong> Tiger Global has been looking into IPL opportunities and conversing with other teams as well. <br /><br /><strong>7.</strong> The Rajasthan Royals' stock was purchased by US-based RedBird Capital in 2021, valuing the organisation at more than $250 million. While a representative for Tiger Global declined to comment, the executive chairperson of the Rajasthan Royals said there were no active transactions when contacted for comment. <br /><br /><strong>8.</strong> Current investments of Tiger Global in India include well-known digital businesses like Flipkart, Ola, Zomato, and Delhivery. Tiger Global also owns a share in Dream Sports, the organisation that runs the online fantasy game website Dream11, in addition to holding assets in the quick-service restaurant chain Wow! Momo and the tea brand Chaayos. <br /><br /><strong>9.</strong> In contrast to the US, UK, and Europe, where institutional money have been active investors in sports leagues, this trend is only now beginning to take hold in India. CVC Capital Partners was the first private equity company to purchase an IPL team in 2021. <br /><br /><strong>10.</strong> Tiger worldwide's proposed investment in the Rajasthan Royals is viewed as an opportunity and is unrelated to recent losses the company suffered in its worldwide IT portfolio. <br /><br /><strong>11.</strong> The value of the IPL has significantly increased, growing by 75% in terms of dollars since 2020 to reach $10.9 billion in 2022. The Board of Control for Cricket in India (BCCI), which inked a $6.2-billion media rights contract, and the auction of two new IPL clubs, Gujarat Titans and Lucknow Super Giants, for a combined $1.6-billion worth, are credited with the valuation increase. The IPL's valuation, which increased by 90% in rupee terms, was calculated using the discounted cash flow (DCF) approach by the consulting company D and P Advisory. Disney Star purchased the broadcast rights for Rs 23,575 crore, and Viacom18 purchased the digital rights for Rs 23,758 crore over a five-year term. The media rights were acquired separately for television and internet platforms.</p>
<span style="font-weight: 400;">Investing in the unlisted market can offer unique opportunities for investors looking to diversify their portfolio and potentially earn significant returns. However, navigating this market can be complex, and selecting the right broker is crucial to ensure a seamless and secure investment experience. The Unlisted market is not regulated hence it becomes very important to identify a right broker. In this article, we will explore the key factors to consider when identifying the right broker in the unlisted market in India.</span> <strong>Reputation and Track Record:</strong> <span style="font-weight: 400;">Researching the reputation and track record of a broker is vital. Look for brokers with a solid reputation, preferably with a significant presence and experience in the unlisted market. Seek recommendations from experienced investors, explore online forums, and read reviews to gauge the broker's reliability, transparency, and ethical practices.</span> <strong>Range of Offerings:</strong> <span style="font-weight: 400;">Consider the range of offerings provided by the broker. A reputable broker in the unlisted market should provide access to a wide selection of companies and investment opportunities. Assess whether they offer diverse sectors, startups, SMEs, or specific industries that align with your investment objectives. A broader range of offerings increases the chances of finding suitable investment options.</span> <strong>Research and Due Diligence:</strong> <span style="font-weight: 400;">A reliable broker should provide comprehensive research and due diligence reports on the companies available in the unlisted market. Thorough research is essential for assessing the potential risks and returns associated with each investment opportunity. Look for brokers who provide access to detailed company profiles, financial information, business models, and growth prospects to make informed investment decisions.</span> <strong>Transparency and Disclosure:</strong> <span style="font-weight: 400;">Transparency and disclosure are critical factors when dealing with a broker in the unlisted market. The broker should be forthcoming with information regarding fees, charges, commissions, and the overall investment process. Clear communication about risks, potential returns, and any conflicts of interest is essential. Ensure that the broker provides regular updates and statements to keep you informed about your investments.</span> <strong>Technology and Platform:</strong> <span style="font-weight: 400;">Evaluate the technology and platform provided by the broker. A user-friendly and secure online platform can greatly enhance your investment experience. Look for brokers who offer robust trading platforms, mobile applications, and access to real-time market data. Additionally, consider the availability of customer support and the ease of executing trades and accessing investment-related information.</span> <strong>Customer Service:</strong> <span style="font-weight: 400;">Efficient customer service is crucial when dealing with a broker. Ensure that the broker has a responsive and knowledgeable customer support team. Prompt resolution of queries, assistance with technical issues, and reliable support for investment-related matters are vital for a satisfactory experience.</span> <span style="font-weight: 400;">Selecting the right broker in the unlisted market requires careful consideration of various factors, including regulatory compliance, reputation, range of offerings, research capabilities, transparency, technology, and customer service. By conducting thorough due diligence and considering these key aspects, you can identify a reputable and trustworthy broker who can guide you through the unlisted market and help you make informed investment decisions. Remember to always assess your risk tolerance and consult with a financial advisor before making any investment decisions.</span>
<strong>Introduction</strong> Capital Small Finance Bank, a leading player in India's banking sector, has announced its financial results for FY23. The results reveal a promising growth trajectory, reinforcing the bank's strong position in the market. This article provides a comprehensive analysis of these results, focusing on key financial metrics. <strong>Interest Income</strong> The bank's interest income, a critical revenue stream, saw a significant increase, rising from INR 578 crores in FY22 to INR 676 crores in FY23. This growth underscores the success of Capital Small Finance Bank's lending operations and its ability to generate substantial revenue from its core business. <strong>Total Income</strong> Total income, another crucial financial indicator, also experienced a notable uptick, moving from INR 632 crores in FY22 to INR 725 crores in FY23. This increase reflects the bank's ability to diversify its income sources and maximize its revenue streams, a key factor in the Capital Small Finance Bank results. <strong>Net Interest Income</strong> Net interest income, a key profitability indicator for banks, rose from INR 256 crores in FY22 to INR 322 crores in FY23. This growth in net interest income underscores Capital Small Finance Bank's efficient interest-earning strategies and its ability to manage interest expenses effectively. <strong>Operational Cost</strong> However, the bank's operational cost also increased from INR 194 crores in FY22 to INR 222 crores in FY23. This rise in operational cost is often associated with expansion activities and investments in infrastructure, indicating the bank's commitment to growth and service improvement. <strong>Profit After Tax (PAT)</strong> Despite the increase in operational cost, the bank's Profit After Tax (PAT) witnessed a significant jump, moving from INR 62 crores in FY22 to INR 93 crores in FY23. This increase in PAT is a positive sign of the bank's profitability and its ability to manage its expenses effectively, a highlight of the Capital Small Finance Bank results. <strong>Net Worth and Book Value</strong> The bank's net worth also increased from INR 515 crores in FY22 to INR 610 crores in FY23, indicating a strengthening of the bank's financial position. The book value per share also rose from INR 151 in FY22 to INR 180 in FY23, further reinforcing the bank's strong financial standing. <strong>Gross Non-Performing Assets (G-NPA)</strong> However, the Gross Non-Performing Assets (G-NPA) slightly increased from 2.50% in FY22 to 2.77% in FY23. This slight increase in G-NPA is a point of attention for the bank's asset quality management. <strong>Valuation and Unlisted Share Price</strong> In terms of valuation, the bank's current unlisted share price stands at INR 350 with a book value of INR 179, resulting in a Price to Book (P/B) ratio of 1.95x. This P/B ratio suggests that the market values the bank at nearly twice its book value, indicating investor confidence in the bank's future growth prospects. <strong>Conclusion</strong> In conclusion, the Capital Small Finance Bank results for FY23 show a promising growth trajectory. Despite the slight increase in G-NPA, the bank's strong performance across key financial metrics indicates a robust financial position and a promising outlook for future growth. The bank's unlisted share price also reflects the market's positive sentiment towards the bank's future prospects https://unlistedzone.com/shares/buy-sell-share-price-capital-small-finance-bank-sfb-unlisted-shares/
<p><strong>NSE Unlisted Shares: <br /><br />A Comprehensive Analysis of FY23 Financial Performance</strong> <br /><br />The National Stock Exchange (NSE), one of India's leading stock exchanges, has shown a remarkable financial performance in FY23. This article will delve into the details of NSE's financials, highlighting the key factors contributing to its growth and comparing its valuation with the Bombay Stock Exchange (BSE).<br /><br /><strong>Revenue Growth: A Surge in FnO Volumes<br /><br /></strong> In FY23, NSE reported a revenue of 12765 Cr, a significant increase from the 8873 Cr in FY22. The primary driver for this revenue growth has been the substantial increase in Futures and Options (FnO) volumes. The surge in FnO volumes indicates a growing interest among investors in derivative trading, which has proven to be a lucrative business segment for the exchange.</p> <table> <thead> <tr> <th style="text-align: center;">Fiscal Year</th> <th style="text-align: center;">Equity (Index and Stock) Volume (Lk Cr)</th> <th style="text-align: center;">Currency Volume (k Cr)</th> </tr> </thead> <tbody> <tr> <td style="text-align: center;">FY20</td> <td style="text-align: center;">14</td> <td style="text-align: center;">41</td> </tr> <tr> <td style="text-align: center;">FY21</td> <td style="text-align: center;">27</td> <td style="text-align: center;">50</td> </tr> <tr> <td style="text-align: center;">FY22</td> <td style="text-align: center;">71</td> <td style="text-align: center;">87</td> </tr> <tr> <td style="text-align: center;">FY23</td> <td style="text-align: center;">153</td> <td style="text-align: center;">155</td> </tr> </tbody> </table> <p>[<em>Please note that "Lk Cr" stands for Lakh Crores and "k Cr" stands for Thousand Crore</em>]<br /><br /><strong>Expense Management: An Increase in Operational Costs</strong> <br /><br />On the expense front, NSE's expenses increased from 2008 Cr in FY22 to 2608 Cr in FY23. This rise in expenses, despite the increase in business volumes, could be attributed to various factors such as expansion initiatives, technology upgrades, or regulatory costs, which need to be examined in detail.<br /><br /><strong>Profit After Tax (PAT) and Earnings Per Share (EPS)</strong> <br /><br />Due to the impressive revenue growth and not much rise in expenses, NSE's Profit After Tax (PAT) for FY23 stood at 7355 Cr, higher than the 5198 Cr reported in FY22. This increase in PAT, coupled with an increase in Earnings Per Share (EPS) from 102 in FY22 to 148 in FY23, indicates a positive trend in profitability. This is a positive sign for investors, indicating better profitability per share. <br /><br /><strong>Dividend Announcement: A Reward for Shareholders</strong> <br /><br />NSE has announced a dividend of 80 per share for FY23, almost double the 42 per share announced in FY22. This increase in dividend payout is a clear indication of the exchange's commitment to rewarding its shareholders and reflects its strong financial health. <br /><br /><strong>Valuation: NSE vs BSE</strong> <br /><br />When it comes to valuation, NSE is available at a Price to Earnings (P/E) ratio of 22x at Rs.3300 per share in the unlisted market. In comparison, BSE is available at a P/E of 35x. This lower P/E ratio for NSE suggests that it is undervalued compared to BSE, making NSE unlisted shares a potentially attractive investment opportunity. <br /><br /><strong>Conclusion</strong> <br /><br />The financial performance of NSE in FY23 paints a picture of a robust and growing business. The significant increase in revenue, coupled with a rise in expenses, and increased PAT and EPS all point towards a strong financial position. The attractive valuation of NSE unlisted shares, compared to BSE, further adds to the appeal for investors. However, as with any investment, potential investors should conduct thorough research and consider their risk tolerance before investing in NSE unlisted shares. <br /><br /><strong>FAQs <br /><br /></strong> <strong>1. How can I buy unlisted shares in NSE?</strong> <br /><br /><strong>Ans:</strong> Unlisted shares can be bought through <a href="https://unlistedzone.com/shares/nse-india-limited-unlisted-shares/">UnlistedZone's website</a> or by dropping us an email at <a href="Mailto:[email protected]">[email protected]</a>. <br /><br /><strong>2. Is it good to buy NSE unlisted shares?</strong> <br /><br /><strong>Ans:</strong> Investing in unlisted shares can offer high returns, but it also comes with risks. Investors should thoroughly research and consider their risk tolerance before investing. However, considering NSE cash generation business with monopoly status in FnO it is considered as good investment. <br /><br /><strong>3. How do I find unlisted shares?</strong> <br /><br /><strong>Ans:</strong> Unlisted shares are not traded on the regular stock exchanges. They can be found through <a href="https://unlistedzone.com/shares/">UnlistedZone's website</a>. <br /><br /><strong>4. How do I sell unlisted shares?</strong> <br /><br /><strong>Ans:</strong> Unlisted shares can be sold through the <a href="https://unlistedzone.com/shares/">UnlistedZone's website</a>. The process may take longer than selling listed shares due to the lack of a centralized marketplace. <br /><br /><a href="https://unlistedzone.com/shares/nse-india-limited-unlisted-shares/">https://unlistedzone.com/shares/nse-india-limited-unlisted-shares/</a></p>
Indicative prices, company research and your enquiries — in your pocket. Get price notes on the names you follow and reach our team from anywhere.
